Skip to content

Skin sparing mastectomy with implant reconstruction: clinical outcomes and cost effectiveness of reconstruction in one stage with the use of a collagen matrix. A randomized clinical trial.

Skin sparing mastectomy with implant reconstruction: clinical outcomes and cost effectiveness of reconstruction in one stage with the use of a collagen matrix. A randomized clinical trial. - Skinsparing mastectomy with immediate implant reconstruction.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39753
Enrollment
140
Registered
2012-12-03
Start date
2013-05-14
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Borstreconstructies. Borstkanker breast reconstruction.

Interventions

1. Two stage breast reconstruction after skin sparing mastectomy, with placing of a tissue expander in the first, and implantation of a breast implant in the second stage. 2. One stage immediate bre

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Female patients from the participating hospitals are included if they meet the following criteria: willing and able to participate; aged 18 and over; able to provide informed consent and to complete questionnaires. Women who meet the inclusion criteria are informed about the study by their doctor and recieve a patientletter. There will be the possibility to ask further questions. Patients are included after signing the informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria are: pregnancy or planning a pregnancy during the study; ongoing severe psychiatric illness or mental retardation; evidence of alcohol and/or drug abuse; inability to complete the questionnaires; local or general infection which could jeopardize the surgical objective; extensive local inflammatory reactions; proven or suspected hypersensitivity to materials; immunosuppressive pathologies

Design outcomes

Primary

MeasureTime frame
The primary endpoint of the study is the quality of life as measured by a specific breast related questionnaire (BREAST-Q) pre-operative and at one year after placement of the permanent prosthesis. This questionnaire was elected because it is especially suitable and valid for the post-mastectomy population. In addition measure sexual health with questionaires before surgery and 12 months after surgery. Complication rate (e.g. infection, implant loss, seroma, contraction of the breast), aesthetic outcome (as measured by a panel of experts at one year after placement of the permanent prosthesis), pain, and patient burden with regard to the number of procedures and time invested are secondary outcomes. In addition, we look at cost-effectiveness. The esthetic outcome will be scored from pictures pre-operatively and one year post-operatively following the four point Harris breast scale (excellent-good-fair-poor) by the patient and a surgeonspanel.

Secondary

MeasureTime frame
Secondly we look at the cost-effectiveness of the procedures. The cost-effectiveness using the Dutch tariff QALYs will be calculated based on the EQ-5D.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)